Baidu
map

皮肤性指南

订阅

MedSci主页 / 所有栏目 / 皮肤性指南

2020 EADV指南：寻常型天疱疮和叶状天疱疮的管理（更新版）

2020-08-24 欧洲皮肤病与性病学会 J Eur Acad Dermatol Venereol . 2020 Aug 24.

天疱疮

2020年8月，欧洲皮肤病与性病学会(EADV)更新发布了寻常型天疱疮和叶状天疱疮的管理指南，天疱疮是一组致命性的自身免疫性大疱性疾病，本文主要针对寻常型天疱疮和叶状天疱疮的管理提供指导建议。

中文标题：

2020 EADV指南：寻常型天疱疮和叶状天疱疮的管理（更新版）

英文标题：

Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)

发布机构：

欧洲皮肤病与性病学会

发布日期：

2020-08-24

简要介绍：

2020年8月，欧洲皮肤病与性病学会(EADV)更新发布了寻常型天疱疮和叶状天疱疮的管理指南，天疱疮是一组致命性的自身免疫性大疱性疾病，本文主要针对寻常型天疱疮和叶状天疱疮的管理提供指导建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 EADV指南：寻常型天胞疮和叶状天疱疮的管理（更新版）.pdf)] GetToolGuiderByIdResponse(projectId=1, id=4627e1c00196631e, title=2020 EADV指南：寻常型天疱疮和叶状天疱疮的管理（更新版）, enTitle=Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV), guiderFrom=J Eur Acad Dermatol Venereol . 2020 Aug 24., authorId=0, author=, summary=2020年8月，欧洲皮肤病与性病学会(EADV)更新发布了寻常型天疱疮和叶状天疱疮的管理指南，天疱疮是一组致命性的自身免疫性大疱性疾病，本文主要针对寻常型天疱疮和叶状天疱疮的管理提供指导建议。, cover=https://img.medsci.cn/202098/1599495857698_2020535.jpg, journalId=0, articlesId=null, associationId=1016, associationName=欧洲皮肤病与性病学会, associationIntro=EADV is a non-profit association, founded in 1987, whose mission is to advance excellence in clinical care, research, education and training in the field of dermatology and Venereology and to act as the advocate and educator of patients particularly those with cutaneous or venereal diseases., copyright=0, guiderPublishedTime=Mon Aug 24 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年8月，欧洲皮肤病与性病学会(EADV)更新发布了寻常型天疱疮和叶状天疱疮的管理指南，天疱疮是一组致命性的自身免疫性大疱性疾病，本文主要针对寻常型天疱疮和叶状天疱疮的管理提供指导建议。</p> </div> </div> </div>, tagList=[TagDto(tagId=13546, tagName=天疱疮)], categoryList=[CategoryDto(categoryId=39, categoryName=皮肤性, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=13546, guiderKeyword=天疱疮, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3957, appHits=185, showAppHits=0, pcHits=1378, showPcHits=3772, likes=1, shares=10, comments=17, approvalStatus=1, publishedTime=Tue Sep 08 00:51:22 CST 2020, publishedTimeString=2020-08-24, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Tue Sep 08 00:24:24 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 11:58:21 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 EADV指南：寻常型天胞疮和叶状天疱疮的管理（更新版）.pdf)])
2020 EADV指南：寻常型天胞疮和叶状天疱疮的管理（更新版）.pdf
下载请点击：
评论区 (13)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1221648, encodeId=7bbb122164856, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/B77A538BC95341C71D2D913D9EF671C1/100, createdBy=36312193369, createdName=drliuxiaoming, createdTime=Sun May 22 22:03:09 CST 2022, time=2022-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074436, encodeId=117110e443616, content=正需要，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b032176135, createdName=12061a47m22(暂无昵称), createdTime=Sat Nov 27 09:09:02 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067419, encodeId=7137106e4198b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/15/7274ed1be4747d648e4e2f7f62fae403.jpg, createdBy=d8d65273314, createdName=1482963am12暂无昵称, createdTime=Fri Nov 05 22:45:45 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007061, encodeId=7db4100e061ab, content=不错，很想看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09a71369094, createdName=qijuns, createdTime=Wed Aug 11 21:09:26 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001930, encodeId=c2051001930cf, content=学习啦，棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/10/956fcb05aa73cca69de364b71c5ffa46.jpg, createdBy=158c5136911, createdName=1466a102m75(暂无昵称), createdTime=Fri Jul 23 09:46:20 CST 2021, time=2021-07-23, status=1, ipAttribution=)]
    2022-05-22 drliuxiaoming

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1221648, encodeId=7bbb122164856, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/B77A538BC95341C71D2D913D9EF671C1/100, createdBy=36312193369, createdName=drliuxiaoming, createdTime=Sun May 22 22:03:09 CST 2022, time=2022-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074436, encodeId=117110e443616, content=正需要，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b032176135, createdName=12061a47m22(暂无昵称), createdTime=Sat Nov 27 09:09:02 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067419, encodeId=7137106e4198b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/15/7274ed1be4747d648e4e2f7f62fae403.jpg, createdBy=d8d65273314, createdName=1482963am12暂无昵称, createdTime=Fri Nov 05 22:45:45 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007061, encodeId=7db4100e061ab, content=不错，很想看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09a71369094, createdName=qijuns, createdTime=Wed Aug 11 21:09:26 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001930, encodeId=c2051001930cf, content=学习啦，棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/10/956fcb05aa73cca69de364b71c5ffa46.jpg, createdBy=158c5136911, createdName=1466a102m75(暂无昵称), createdTime=Fri Jul 23 09:46:20 CST 2021, time=2021-07-23, status=1, ipAttribution=)]
    2021-11-27 12061a47m22(暂无昵称)

    正需要，谢谢

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1221648, encodeId=7bbb122164856, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/B77A538BC95341C71D2D913D9EF671C1/100, createdBy=36312193369, createdName=drliuxiaoming, createdTime=Sun May 22 22:03:09 CST 2022, time=2022-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074436, encodeId=117110e443616, content=正需要，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b032176135, createdName=12061a47m22(暂无昵称), createdTime=Sat Nov 27 09:09:02 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067419, encodeId=7137106e4198b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/15/7274ed1be4747d648e4e2f7f62fae403.jpg, createdBy=d8d65273314, createdName=1482963am12暂无昵称, createdTime=Fri Nov 05 22:45:45 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007061, encodeId=7db4100e061ab, content=不错，很想看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09a71369094, createdName=qijuns, createdTime=Wed Aug 11 21:09:26 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001930, encodeId=c2051001930cf, content=学习啦，棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/10/956fcb05aa73cca69de364b71c5ffa46.jpg, createdBy=158c5136911, createdName=1466a102m75(暂无昵称), createdTime=Fri Jul 23 09:46:20 CST 2021, time=2021-07-23, status=1, ipAttribution=)]
    2021-11-05 1482963am12暂无昵称

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1221648, encodeId=7bbb122164856, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/B77A538BC95341C71D2D913D9EF671C1/100, createdBy=36312193369, createdName=drliuxiaoming, createdTime=Sun May 22 22:03:09 CST 2022, time=2022-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074436, encodeId=117110e443616, content=正需要，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b032176135, createdName=12061a47m22(暂无昵称), createdTime=Sat Nov 27 09:09:02 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067419, encodeId=7137106e4198b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/15/7274ed1be4747d648e4e2f7f62fae403.jpg, createdBy=d8d65273314, createdName=1482963am12暂无昵称, createdTime=Fri Nov 05 22:45:45 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007061, encodeId=7db4100e061ab, content=不错，很想看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09a71369094, createdName=qijuns, createdTime=Wed Aug 11 21:09:26 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001930, encodeId=c2051001930cf, content=学习啦，棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/10/956fcb05aa73cca69de364b71c5ffa46.jpg, createdBy=158c5136911, createdName=1466a102m75(暂无昵称), createdTime=Fri Jul 23 09:46:20 CST 2021, time=2021-07-23, status=1, ipAttribution=)]
    2021-08-11 qijuns

    不错，很想看

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1221648, encodeId=7bbb122164856, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/B77A538BC95341C71D2D913D9EF671C1/100, createdBy=36312193369, createdName=drliuxiaoming, createdTime=Sun May 22 22:03:09 CST 2022, time=2022-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074436, encodeId=117110e443616, content=正需要，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b032176135, createdName=12061a47m22(暂无昵称), createdTime=Sat Nov 27 09:09:02 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067419, encodeId=7137106e4198b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/15/7274ed1be4747d648e4e2f7f62fae403.jpg, createdBy=d8d65273314, createdName=1482963am12暂无昵称, createdTime=Fri Nov 05 22:45:45 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007061, encodeId=7db4100e061ab, content=不错，很想看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09a71369094, createdName=qijuns, createdTime=Wed Aug 11 21:09:26 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001930, encodeId=c2051001930cf, content=学习啦，棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/10/956fcb05aa73cca69de364b71c5ffa46.jpg, createdBy=158c5136911, createdName=1466a102m75(暂无昵称), createdTime=Fri Jul 23 09:46:20 CST 2021, time=2021-07-23, status=1, ipAttribution=)]
    2021-07-23 1466a102m75(暂无昵称)

    学习啦，棒

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

2017天疱疮中医诊疗指南

中华中医药学会皮肤科专业委员会 · 2017-01-30

2014 EDF/EADV天疱疮诊断和治疗指南（S2）

欧洲皮肤病学论坛(EDF,European Dermatology Forum) · 2014-10-22

拓展阅读

2014 EDF/EADV天疱疮诊断和治疗指南（S2）

欧洲皮肤病学论坛(EDF,European Dermatology Forum) · 2014-10-22

2017天疱疮中医诊疗指南

中华中医药学会皮肤科专业委员会 · 2017-01-30

2022 TDA共识：天疱疮的管理

中国台湾皮肤科医学会(TDA,Taiwanese Dermatological Association) · 2022-12-21

Baidu
map
Baidu
map
Baidu
map